Emergence of cefiderocol resistance during therapy in NDM-5–producing Klebsiella pneumoniae isolates harboring siderophore receptors mutations

Cefiderocol, a siderophore-conjugated cephalosporine, is a promising drug used to treat infection with carbapenem-resistant gram-negative bacteria. Here, we report a case of pneumonia induced by multiple gram-negative pathogens, including a carbapenem-resistant Klebsiella pneumoniae developing cefid...

Full description

Saved in:
Bibliographic Details
Main Authors: Luc Deroche, Albane Rozenholc, François Arrivé, Jean-Philippe Martellosio, Gwenaël Le Moal, Arnaud W. Thille, Olivier Barraud, Sandrine Marchand, Julien M. Buyck
Format: Article
Language:English
Published: Elsevier 2025-02-01
Series:International Journal of Infectious Diseases
Subjects:
Online Access:http://www.sciencedirect.com/science/article/pii/S1201971224003965
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1846117956902191104
author Luc Deroche
Albane Rozenholc
François Arrivé
Jean-Philippe Martellosio
Gwenaël Le Moal
Arnaud W. Thille
Olivier Barraud
Sandrine Marchand
Julien M. Buyck
author_facet Luc Deroche
Albane Rozenholc
François Arrivé
Jean-Philippe Martellosio
Gwenaël Le Moal
Arnaud W. Thille
Olivier Barraud
Sandrine Marchand
Julien M. Buyck
author_sort Luc Deroche
collection DOAJ
description Cefiderocol, a siderophore-conjugated cephalosporine, is a promising drug used to treat infection with carbapenem-resistant gram-negative bacteria. Here, we report a case of pneumonia induced by multiple gram-negative pathogens, including a carbapenem-resistant Klebsiella pneumoniae developing cefiderocol resistance within 32 days of cefiderocol therapy. Whole genome sequencing of three consecutive K. pneumoniae isolates revealed that the bacteria were isogenic and were carrying several broad-spectrum β-lactamases (blaNDM5 and blaCTX-M-15). Two isolates with elevated minimum inhibitory concentration against cefiderocol harbored mutations in genes encoding siderophore: one in the cirA gene and one in both the cirA and the fiu genes. The combination of a metallo-β-lactamase background and mutations in siderophore receptors was associated with phenotypic resistance to cefiderocol.
format Article
id doaj-art-23f8582a785743c08b5269b68dbac8a0
institution Kabale University
issn 1201-9712
language English
publishDate 2025-02-01
publisher Elsevier
record_format Article
series International Journal of Infectious Diseases
spelling doaj-art-23f8582a785743c08b5269b68dbac8a02024-12-18T08:47:35ZengElsevierInternational Journal of Infectious Diseases1201-97122025-02-01151107321Emergence of cefiderocol resistance during therapy in NDM-5–producing Klebsiella pneumoniae isolates harboring siderophore receptors mutationsLuc Deroche0Albane Rozenholc1François Arrivé2Jean-Philippe Martellosio3Gwenaël Le Moal4Arnaud W. Thille5Olivier Barraud6Sandrine Marchand7Julien M. Buyck8Université de Poitiers, PHAR2, Inserm U1070, Poitiers, France; CHU de Poitiers, Département des agents infectieux, Poitiers, FranceUniversité de Poitiers, PHAR2, Inserm U1070, Poitiers, FranceCHU de Poitiers, Service de Médecine Intensive - Réanimation, Poitiers, FranceCHU de Poitiers, Service de Médecine Interne, maladies infectieuses et tropicales, Poitiers, FranceCHU de Poitiers, Service de Médecine Interne, maladies infectieuses et tropicales, Poitiers, FranceCHU de Poitiers, Service de Médecine Intensive - Réanimation, Poitiers, FranceUniversité Limoges, INSERM, CHU Limoges, UMR 1092, Limoges, France; Clinical Investigation Center CIC1435, CHU Limoges, Limoges, FranceUniversité de Poitiers, PHAR2, Inserm U1070, Poitiers, France; CHU de Poitiers, Laboratoire de Toxicologie et de Pharmacocinétique, Poitiers, FranceUniversité de Poitiers, PHAR2, Inserm U1070, Poitiers, France; Corresponding author.Cefiderocol, a siderophore-conjugated cephalosporine, is a promising drug used to treat infection with carbapenem-resistant gram-negative bacteria. Here, we report a case of pneumonia induced by multiple gram-negative pathogens, including a carbapenem-resistant Klebsiella pneumoniae developing cefiderocol resistance within 32 days of cefiderocol therapy. Whole genome sequencing of three consecutive K. pneumoniae isolates revealed that the bacteria were isogenic and were carrying several broad-spectrum β-lactamases (blaNDM5 and blaCTX-M-15). Two isolates with elevated minimum inhibitory concentration against cefiderocol harbored mutations in genes encoding siderophore: one in the cirA gene and one in both the cirA and the fiu genes. The combination of a metallo-β-lactamase background and mutations in siderophore receptors was associated with phenotypic resistance to cefiderocol.http://www.sciencedirect.com/science/article/pii/S1201971224003965CefiderocolAntibiotic resistanceKlebsiella pneumoniaeSiderophore receptorWGS
spellingShingle Luc Deroche
Albane Rozenholc
François Arrivé
Jean-Philippe Martellosio
Gwenaël Le Moal
Arnaud W. Thille
Olivier Barraud
Sandrine Marchand
Julien M. Buyck
Emergence of cefiderocol resistance during therapy in NDM-5–producing Klebsiella pneumoniae isolates harboring siderophore receptors mutations
International Journal of Infectious Diseases
Cefiderocol
Antibiotic resistance
Klebsiella pneumoniae
Siderophore receptor
WGS
title Emergence of cefiderocol resistance during therapy in NDM-5–producing Klebsiella pneumoniae isolates harboring siderophore receptors mutations
title_full Emergence of cefiderocol resistance during therapy in NDM-5–producing Klebsiella pneumoniae isolates harboring siderophore receptors mutations
title_fullStr Emergence of cefiderocol resistance during therapy in NDM-5–producing Klebsiella pneumoniae isolates harboring siderophore receptors mutations
title_full_unstemmed Emergence of cefiderocol resistance during therapy in NDM-5–producing Klebsiella pneumoniae isolates harboring siderophore receptors mutations
title_short Emergence of cefiderocol resistance during therapy in NDM-5–producing Klebsiella pneumoniae isolates harboring siderophore receptors mutations
title_sort emergence of cefiderocol resistance during therapy in ndm 5 producing klebsiella pneumoniae isolates harboring siderophore receptors mutations
topic Cefiderocol
Antibiotic resistance
Klebsiella pneumoniae
Siderophore receptor
WGS
url http://www.sciencedirect.com/science/article/pii/S1201971224003965
work_keys_str_mv AT lucderoche emergenceofcefiderocolresistanceduringtherapyinndm5producingklebsiellapneumoniaeisolatesharboringsiderophorereceptorsmutations
AT albanerozenholc emergenceofcefiderocolresistanceduringtherapyinndm5producingklebsiellapneumoniaeisolatesharboringsiderophorereceptorsmutations
AT francoisarrive emergenceofcefiderocolresistanceduringtherapyinndm5producingklebsiellapneumoniaeisolatesharboringsiderophorereceptorsmutations
AT jeanphilippemartellosio emergenceofcefiderocolresistanceduringtherapyinndm5producingklebsiellapneumoniaeisolatesharboringsiderophorereceptorsmutations
AT gwenaellemoal emergenceofcefiderocolresistanceduringtherapyinndm5producingklebsiellapneumoniaeisolatesharboringsiderophorereceptorsmutations
AT arnaudwthille emergenceofcefiderocolresistanceduringtherapyinndm5producingklebsiellapneumoniaeisolatesharboringsiderophorereceptorsmutations
AT olivierbarraud emergenceofcefiderocolresistanceduringtherapyinndm5producingklebsiellapneumoniaeisolatesharboringsiderophorereceptorsmutations
AT sandrinemarchand emergenceofcefiderocolresistanceduringtherapyinndm5producingklebsiellapneumoniaeisolatesharboringsiderophorereceptorsmutations
AT julienmbuyck emergenceofcefiderocolresistanceduringtherapyinndm5producingklebsiellapneumoniaeisolatesharboringsiderophorereceptorsmutations